Apitope announces IPO to fund MS drug developmentBiotech Apitope plans to float on the Brussels stock exchange to raise funds to develop a potential new Share XApitope announces IPO to fund MS drug developmenthttps://pharmaphorum.com/news/apitope-announces-ipo-fund-ms-drug-development/
Apitope aims to bounce back from MS setbackBiotech looks for funding and long-term development partner Share XApitope aims to bounce back from MS setbackhttps://pharmaphorum.com/news/apitope-aims-bounce-back-ms-setback/
Apitope to develop MS drug, Merck KGaA tie-up endsAnglo-Belgian biotech will continue clinical development. Share XApitope to develop MS drug, Merck KGaA tie-up endshttps://pharmaphorum.com/news/apitope-develop-ms-drug-merck-kgaa-tie-ends/